Ethambutolum [INN-Latin] en es it fr

Ethambutolum [INN-Latin] Brand names, Ethambutolum [INN-Latin] Analogs

Ethambutolum [INN-Latin] Brand Names Mixture

  • No information avaliable

Ethambutolum [INN-Latin] Chemical_Formula


Ethambutolum [INN-Latin] RX_link

Ethambutolum [INN-Latin] fda sheet

Ethambutolum [INN-Latin] msds (material safety sheet)

Ethambutolum [INN-Latin] Synthesis Reference

No information avaliable

Ethambutolum [INN-Latin] Molecular Weight

204.225 g/mol

Ethambutolum [INN-Latin] Melting Point

94 oC

Ethambutolum [INN-Latin] H2O Solubility

5280 mg/L

Ethambutolum [INN-Latin] State


Ethambutolum [INN-Latin] LogP


Ethambutolum [INN-Latin] Dosage Forms

Tablet (250, 500 mg)

Ethambutolum [INN-Latin] Indication

For the control of tonic-clonic (grand mal) and complex partial (psychomotor) seizures.

Ethambutolum [INN-Latin] Pharmacology

Ethotoin is a hydantoin derivative and anticonvulsant. Ethotoin exerts an antiepileptic effect without causing general central nervous system depression. The mechanism of action is probably very similar to that of phenytoin. The latter drug appears to stabilize rather than to raise the normal seizure threshold, and to prevent the spread of seizure activity rather than to abolish the primary focus of seizure discharges.

Ethambutolum [INN-Latin] Absorption

Fairly rapidly absorbed, however, the extent of oral absorption is not known.

Ethambutolum [INN-Latin] side effects and Toxicity

Symptoms of overdose include drowsiness, loss of or impaired muscle coordination, nausea, visual disturbance, and, at very high doses, coma.

Ethambutolum [INN-Latin] Patient Information

Ethambutolum [INN-Latin] Organisms Affected

Humans and other mammals